TABLE 3.

Summary of the Adverse Events observed in the trial [SS].

	Treatment group			Control group			Total
	N = 102			N = 103			N = 205
	Cases	n	Incidence (%)	Cases	n	Incidence (%)	Cases	n	Incidence (%)
Adverse events	0	0	0.0	2	1	1.0	2	1	0.5
Adverse drug reactions	0	0	0.0	0	0	0.0	0	0	0.0
Serious Adverse events	0	0	0.0	0	0	0.0	0	0	0.0